TAUZIN DEFENDS DIRECT-TO-CONSUMER Rx ADVERTISING

JANUARY 01, 2006

While the FDA takes a fresh look at the impact of direct-to-consumer (DTC) advertising of prescription drugs, manufacturers of prescription medicines say the evidence supporting the value of these ads is clear-cut. "There is no doubt that DTC advertising is an invaluable communications tool that empowers millions of Americans to talk to health care professionals about their medical conditions," Pharmaceutical Research and Manufacturers of America President and Chief Executive Officer Billy Tauzin said.

Tauzin, a former congressman actively involved in health care issues, argued that consumer ads for prescription products give physicians an opportunity to discuss the risks and benefits of courses of treatments—a dialogue that produces more informed patients.

"The educational value of DTC advertising is particularly important to address underdiagnosis and undertreatment of major medical conditions such as asthma, cerebral vascular disease, diabetes, and hypertension," he said.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.